Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Melatonin as an Adjuvant Therapy for Preterm Neonates With Sepsis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Newborns with gestational age of 28-36+6 weeks, birth weight according to gestational age, and diagnosis of sepsis based on HPS and PRS sepsis score criteria~Exclusion Criteria:~* Major congenital anomalies of the gastrointestinal tract.~* Continuous vomiting.~* Newborns with hypoxic ischemic encephalopathy (HIE), intracranial hemorrhage, feeding intolerance, necrotizing enterocolitis (NEC) and hormonal disorders.~* Septic shock.

- Gender: ALL
- Minimum Age: 28 Weeks
- Maximum Age: 36 Weeks
- Healthy Volunteers: f

Study Arms:
- Control Group (Type: PLACEBO_COMPARATOR): The control group will receive standard therapy and placebo.
- Treatment Group (Type: EXPERIMENTAL): The participants in the treatment group will receive standard therapy and a single dose of oral melatonin 20 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).